This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Persistent or recurrent NGU (non - gonococcal urethritis)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Is defined as persistent or recurrent symptomatic urethritis occurring 30-90 days following treatment of acute NGU. It is seen in around 10%-20% of patients.

Aetilogy is most likely to be multifactorial but M. genitalium (found in 20%-40%) and U. urealyticum have been implicated.

Before starting treatment

  • reinfection should be ruled out and make certain that the patient has taken the full course of therapy initially prescribed
  • definite symptoms of urethritis (or physical signs on examination) should be present

In patients with symptoms or obvious discharge recommended regimens include:

  • 1st line
    • Azithromycin 500mg stat then 250mg for the next 4 days plus Metronidazole 400 mg twice daily for 5 days
    • or
      • Erythromycin 500 mg four times daily for 3 weeks plus Metronidazole 400mg twice daily for 5 days
  • 2nd line
    • Moxifloxacin 400mg orally once daily for 10 days plus Metronidazole 400mg twice daily for 5 days (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.